Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanchi Tongshu capsule versus Xuesaitong capsule plus aspirin for ischemic stroke
ChiCTR2400088419Phase 4Completed
- Sponsor
- Henan Provincial Hospital of Traditional Chinese Medicine
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sanqi tongshu in ischemic stroke (2 arms), sponsored by Henan Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Proportion of subjects with modified Rankin Scale score 2 or less and Change from baseline in stroke-specific quality of life score. Started Aug 2024; status: completed.
02
Drugs
sanqi tongshu
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2400088419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088419.